Skip to main content Skip to navigation

SMA Newborn Screening Study

Mother holding newborn baby

SMA Newborn Screening Study

We are conducting a number of surveys and interviews to gather views on whether Spinal Muscular Atrophy should be added to the list of conditions that newborn babies are routinely screened for in the UK (heel prick, bloodspot, or Guthrie test).

We will be looking for participants from the general public, parents who are taking part in the SMA newborn screening pilot, people with SMA and their family members, and health care professionals.

For more information please contact SMAscreening@warwick.ac.uk

Who is conducting the study?

The newborn screening study is being led by Prof Felicity Boardman with Dr Corinna Clark at the University of Warwick.

The study is linked to the first UK pilot of Newborn Screening for SMA being led by Prof Laurent Servais at the University of Oxford.

The study is funded by Novartis.

Coming soon....Survey for parents taking part in SMA Screening Pilot

Survey to gather the views of parents who have been offered screening for SMA as part of the study “Population-based New-Born Screening of Spinal Muscular Atrophy to evaluate the uptake and feasibility in the UK context” being led by Prof Laurent Servais at Oxford University

Coming soon...Survey for members of the general public on newborn SMA screening

Survey to gather the views of members of the public on adding screening for Spinal Muscular Atrophy to existing newborn blood-spot screening

Coming soon...Survey for people with SMA and their family members

Survey to gather the views of people with Spinal Muscular Atrophy, and their family members, on adding screening for SMA to existing newborn blood-spot screening

This page will be updated with more information about the study and how to participate soon. Please contact either or if you have any questions about the study.